Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


The NIH starts spending $1.5 billion in new Brain Research through Advancing Innovative Neuro-technologies (BRAIN) projects


NIH Starts to Spend $4.8 Bil­lion in “Extra” Cures Drug Research Mon­ey (P&T Com­mu­ni­ty):

The Nation­al Insti­tutes of Health (NIH) launched 110 new brain research projects in the fis­cal year end­ing last Sep­tem­ber (2017) with the first por­tion of the $1.5 bil­lion over 10 years it will hope­ful­ly receive from the 21st Cen­tu­ry Cures Act, which spread a total of $4.8 bil­lion over four NIH pro­grams. That is mon­ey over and above the NIH annu­al appro­pri­a­tion from Con­gress. The oth­er three “Inno­va­tion Funds” are: Pre­ci­sion Med­i­cine, Can­cer Moon­shot, and Regen­er­a­tive Med­i­cine.

The $1.5 bil­lion in new Brain Research through Advanc­ing Inno­v­a­tive Neu­ro-tech­nolo­gies (BRAIN) research mon­ey seems par­tic­u­lar­ly impor­tant giv­en the announce­ment in Jan­u­ary that Pfiz­er was end­ing its Alzheimer’s research pro­gram after years of fruit­less devel­op­ment efforts, which have plagued oth­er com­pa­nies as well…A prime exam­ple is the “All of Us” ini­tia­tive, which is the pri­ma­ry focus of the Pre­ci­sion Med­i­cine Ini­tia­tive (PMI). While the FDA is using Cures mon­ey to aggre­gate patient post-mar­ket­ing data, the NIH will be col­lect­ing patient data in order to learn about med­ical con­di­tions and to assem­ble a crit­i­cal mass of poten­tial clin­i­cal tri­al par­tic­i­pants. The NIH is part­ner­ing with five com­pa­nies to cre­ate a par­tic­i­pant tech­nol­o­gy cen­ter.

Get­ting all these part­ners on board would have been near­ly impos­si­ble had not the Cures Act includ­ed some­thing called Oth­er Trans­ac­tions Author­i­ty for PMI, mak­ing it pos­si­ble for NIH to move for­ward with unprece­dent­ed speed and flex­i­bil­i­ty to car­ry out beta test­ing of all the many com­po­nents, and now a planned launch in the spring of 2018,” NIH Direc­tor Fran­cis Collins, MD, PhD, told the House Ener­gy and Com­merce Com­mit­tee on Novem­ber 30, 2017. “It will also be a plat­form where many clin­i­cal tri­als can also get start­ed because these par­tic­i­pants will have been pre-con­sent­ed for con­tact to see if they would be inter­est­ed in tak­ing part in a clin­i­cal tri­al, say, for dia­betes or Alzheimer’s risks.”

News in Context

Leave a Reply...

Loading Facebook Comments ...

Leave a Reply

Categories: Cognitive Neuroscience, Health & Wellness, Technology

Tags: , , , , , , , , ,

Search in our archives

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Follow us and Engage via…

RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)